DexCom, Inc.
DXCM
Pozycja w akcjach
#760
DexCom, Inc. is a medical technology company primarily focused on innovating,... DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.
Cena akcji
$85.72
Ostatnia synchronizacja: 2026-10-20
Kapitalizacja rynkowa
$32.35B
Zmiana (1 dzień)
-0.30%
Zmiana (1 rok)
22.90%
Kraj
US
Handel DexCom, Inc. (DXCM)
Kategoria
Healthcare
Przychody dla DexCom, Inc. (DXCM)
Przychody w Jun 2026 TTM: $4.97B
Według najnowszych raportów finansowych DexCom, Inc., obecny przychód firmy (TTM) wynosi $4.97B. W roku 2024 firma osiągnęła przychód w wysokości $4.03B wzrost w porównaniu do przychodu z roku 2023, który wynosił $3.62B. Przychód to całkowita kwota dochodu generowana przez firmę ze sprzedaży towarów lub usług. W przeciwieństwie do zysku, nie są odliczane żadne koszty.
Historia przychodów firmy DexCom, Inc. od 2000 do 2026
Przychody na koniec każdego roku
| Rok | Przychody | Zmień |
|---|---|---|
| 2026 (TTM) | $4.97B | 6.59% |
| 2025 | $4.66B | 15.60% |
| 2024 | $4.03B | 11.34% |
| 2023 | $3.62B | 24.49% |
| 2022 | $2.91B | 18.84% |
| 2021 | $2.45B | 27.08% |
| 2020 | $1.93B | 30.54% |
| 2019 | $1.48B | 43.08% |
| 2018 | $1.03B | 43.58% |
| 2017 | $718.50M | 25.33% |
| 2016 | $573.30M | 42.61% |
| 2015 | $402.00M | 55.09% |
| 2014 | $259.20M | 62.00% |
| 2013 | $160.00M | 60.16% |
| 2012 | $99.90M | 30.99% |
| 2011 | $76.27M | 56.83% |
| 2010 | $48.63M | 63.78% |
| 2009 | $29.69M | 201.82% |
| 2008 | $9.84M | 112.62% |
| 2007 | $4.63M | 113.25% |
| 2006 | $2.17M | 0.00% |
| 2005 | 0.00 | 0.00% |
| 2004 | 0.00 | 0.00% |
| 2003 | 0.00 | 0.00% |
| 2002 | 0.00 | 0.00% |
| 2001 | 0.00 | 0.00% |
| 2000 | 0.00 | 0.00% |
Przychody podobnych firm lub konkurentów
| Firma | Przychody | Różnica w przychodach | Kraj |
|---|---|---|---|
| $46.59B | 837.47% |
US
|
|
| $35.48B | 614.08% |
IE
|
|
| $25.84B | 419.94% |
US
|
|
| $21.00B | 322.52% |
US
|
|
| - | - |
DE
|
